LinkedIn Profile

Access Cambridge Cancer Genomics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:ccgai 11000129 Mar 18th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 18th, 2023 07:15PM Mar 18th, 2023 07:15PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 17th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 17th, 2023 01:16PM Mar 17th, 2023 01:16PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 16th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 16th, 2023 06:15PM Mar 16th, 2023 06:15PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 15th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 15th, 2023 03:03PM Mar 15th, 2023 03:03PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 14th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 14th, 2023 03:27PM Mar 14th, 2023 03:27PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 13th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 13th, 2023 05:47PM Mar 13th, 2023 05:47PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 12th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 12th, 2023 03:28PM Mar 12th, 2023 03:28PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 11th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 11th, 2023 05:26PM Mar 11th, 2023 05:26PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 10th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 10th, 2023 07:32PM Mar 10th, 2023 07:32PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics
private:ccgai 11000129 Mar 9th, 2023 12:00AM Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs) 2.9K 2.00 Open Biotechnology Research Mar 9th, 2023 05:50PM Mar 9th, 2023 05:50PM Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. Open cancer, therapy, diagnostics, Artificial intelligence , and machine learning Open Future Business Centre Cambridge Cambridgeshire GB CB4 2HY Cambridge Cancer Genomics

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.